March 2017 FDA Recall Atenolol by Zydus Pharmaceuticals Usa Inc
D-0605-2017 - Presence of Foreign Tablets/Capsules

This Class II drug recall was voluntarily initiated by Zydus Pharmaceuticals Usa Inc on March 6, 2017 for the product Atenolol. The FDA reported the reason for recall as presence of foreign tablets/capsules. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0605-2017

Reason for Recall
Presence of Foreign Tablets/Capsules: Customer complaint that a bottle of atenolol 50 mg Tablets USP contained a paroxetine 20 mg tablet.
Initiated
03-06-2017
Reported
03-29-2017
Quantity
9561 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Zydus Pharmaceuticals USA Inc
Nationwide in the USA and Puerto Rico.
ATENOLOL Tablets, USP, 50 mg, packaged in a) 100-count bottles (NDC 68382-023-01) and b) 1000-count bottles (NDC 68382-023-10), Rx only, Manufactured by: Cadila Healthcare Ltd., India; Distributed by: Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534.

Batch or Lot Expiration Information

Lot# : a) Z600724, Exp 04/18; Z600725, Exp 04/18